The Board of Directors of Dr. Lal PathLabs is scheduled to meet on January 30, 2026, to consider the declaration of a 3rd Interim Dividend for the financial year 2025-26. The meeting will also involve reviewing and approving the Un-audited (Standalone & Consolidated) Financial Results for the quarter and nine months ending December 31, 2025.
Board Meeting Scheduled
Dr. Lal PathLabs has announced that a meeting of its Board of Directors will be held on January 30, 2026.
Agenda Highlights
The primary focus of the meeting is to consider the declaration of a 3rd Interim Dividend, if any, for the financial year 2025-26. Additionally, the board will review and approve the Un-audited (Standalone & Consolidated) Financial Results for the quarter and nine months that ended on December 31, 2025.
Source: BSE
